clinical trial · NCT06283641
Study to Evaluate the Safety and Effectiveness of Saxenda® for Weight Management in Routine Clinical Practice in Taiwan.
Novo Nordisk A/S·—·completed·n = 300
ObesityLiraglutide
brief summary
This is a non-interventional study to evaluate the safety and effectiveness of Saxenda® in obese adults and adolescents in Taiwan. The participants will recieve Saxenda® treatment which is a medicine that doctors can already prescribe. The study will last for about 26 weeks.
started
Apr 8, 2024
primary completion
Jan 13, 2025
completion
Jan 13, 2025
last updated
Jan 9, 2026
official title
Multicentre, Single-arm, Non-interventional Regulatory Post- Marketing Surveillance (rPMS) Study to Evaluate the Safety and Effectiveness of Saxenda® for Weight Management in Routine Clinical Practice in Taiwan.
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol